Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Fierce Health vs Injectco

Fierce Health
Graded #410

Lower grade

vs+7.999999999999993
Injectco
Graded #237

Higher grade

The verdict

Injectco takes it — 64.6/100 to 56.6/100.

Injectco grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Injectco is a Dallas-based medspa offering compounded GLP-1 prescriptions shipped from licensed US partner pharmacies.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueInjectco +39
33
72
Dose & formulationFierce Health +13
77
64
Clinical oversightInjectco +9
62
71
Labs & monitoringInjectco +1
52
53
FulfillmentFierce Health +15
75
60
Contract termsInjectco +8
47
55
Fierce Health · left barInjectco · right bar

The numbers

MetricFierce HealthInjectco
WeighScore56.6/10064.6/100
GradeCC
Scorecard rank#410#237
Semaglutide$297/mo (3-month plan, compounded)$156/mo (compounded)
Tirzepatide$497/mo (3-month plan, compounded)$425/mo (starting dose, compounded)
Coverage30 statesCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
Fierce Health

Graded #410 · C

Strengths

  • 30-state service list spelled out in the Terms — buyers can verify eligibility before intake
  • LegitScript Certified
  • Publishes the FDA compounded-medication disclaimer on every product page
  • Four GLP-1 programs (standard and microdose semaglutide and tirzepatide) — a broader ladder than peers
  • Microdose tier at $197/mo is one of the lower entry points we've seen

Where it loses points

  • No named 503A compounding pharmacy partner — only generic 'partner pharmacies' language
  • Operating LLC name not disclosed anywhere on the site
  • Tirzepatide weight-loss program ($497/mo) showing 'sold out or unavailable' across all plans at review time
  • Clinical provider network not named
  • FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database
Injectco

Graded #237 · C

Strengths

  • Physical address in Dallas TX
  • Founded July 2021 — established
  • Bulk pricing ($1,249 for 6-8 months) can be cost-effective
  • Payment plan available ($156/mo)

Where it loses points

  • Does not specify which GLP-1 drug (semaglutide vs tirzepatide)
  • No LegitScript or PCAB accreditation
  • Primarily a medspa (Botox, fillers, hair restoration)
  • May be Texas-only — unclear if telehealth ships nationally
  • No named pharmacy partners

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard